Autor/in Harbeck, N Huober, J 2 Jackisch, C 2 Möbus, V 2 Schneeweiss, A 2 Thomssen, C 2 von Minckwitz, G 2 Becker, K 1 Bokemeyer, Carsten 1 Bruweleit, Melanie 1 Conrad, B 1 De Wit, Maike 1 Elling, D 1 Fehm, T 1 Hoffmann, R 1 Hossfeld, Dieter 1 Kuhn, W 1 Lück, H J 1 Lück, H-J 1 Nitz, U 1 Schilling, Georgia 1 Schütte, M 1 Tesch, H 1 Villena, C 1 du Bois, A 1 alle zeigenListe einklappen
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial Möbus, V Jackisch, C Lück, H J du Bois, A Thomssen, C Kuhn, W Nitz, U 2018 - Forschungsinformationssystem des UKE
German Adjuvant Intergroup Node-positive Study (GAIN):a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients Möbus, V von Minckwitz, G Jackisch, C Lück, H-J Schneeweiss, A Tesch, H Elling, D 2017 - Forschungsinformationssystem des UKE
Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy). Schilling, Georgia Bruweleit, Melanie Harbeck, N Thomssen, C Becker, K Hoffmann, R Villena, C 2009 - Forschungsinformationssystem des UKE
